A 36-year-old gender nonbinary individual with HIV and a CD4 count of 250 cells/mm3 is seen in clinic for a routine visit. They started taking dolutegravir plus tenofovir alafenamide-emtricitabine 3 months ago and have achieved an undetectable plasma HIV RNA level. They have no acute complaints, but report treatment for three outbreaks of genital herpes since their last clinic visit 6 months ago. They ask about medications that may reduce her genital herpes outbreaks.
Which one of the following regimens would you recommend for suppressive therapy in this individual with HIV?
Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Since you are not signed in, your progress won't be saved.
Question Last Updated
March 29th, 2022
March 29th, 2022
Steps to Acquire CE for this Question Bank Topic:
1
Answer
Answer all questions
2
Score 80%+
Answer correctly
3
Claim CE
Choose CNE or CME+MOC
4
Give Feedback
Complete survey
5